Insulin Detemir and Waist Circumference - Full Text View

Insulin Detemir and Waist Circumference

This study has been completed.

Sponsored by:	University of Roma La Sapienza
Information provided by:	University of Roma La Sapienza
ClinicalTrials.gov Identifier:	NCT00714844

Purpose

The purpose of the study is to investigate the weight-sparing effect of detemir and assess glycemic control and treatment satisfaction when switching from NPH to detemir, to improve metabolic control.

Condition

Type 2 Diabetes

MedlinePlus related topics:

Diabetes

ChemIDplus related topics:

Insulin Insulin Detemir Insulin, isophane

U.S. FDA Resources

Study Type:	Observational
Study Design:	Case-Only, Retrospective

Official Title:	Waist Circumference Reduction After Insulin Detemir Treatment in Type 2 Diabetes Patients Previously Treated With NPH Insulin

Further study details as provided by University of Roma La Sapienza:

Biospecimen Retention: None Retained

Biospecimen Description:

Enrollment:	20
Study Start Date:	January 2007
Study Completion Date:	October 2007
Primary Completion Date:	October 2007 (Final data collection date for primary outcome measure)

Eligibility

Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

Type 2 diabetic patients accessing the Diabetologic Centre

Criteria

Inclusion Criteria:

Duration of type 2 diabetes for at least 12 months
BMI <40 kg/m2
HbA1c >7.5%
Requiring basal insulin replacement and previously treated with NPH insulin

Contacts and Locations

No Contacts or Locations Provided

More Information

Responsible Party:	University of Roma La Sapienza, Policlinico Umberto I, Dpt Scienze Cliniche ( Susanna Morano )
Study ID Numbers:	PolUmbI-DptSClin-Det1
First Received:	July 7, 2008
Last Updated:	July 7, 2008
ClinicalTrials.gov Identifier:	NCT00714844
Health Authority:	Italy: Ethics Committee

Keywords provided by University of Roma La Sapienza:

insulin therapy

insulin detemir

waist circumference

Study placed in the following topic categories:

Metabolic Diseases

Diabetes Mellitus, Type 2

Diabetes Mellitus

Endocrine System Diseases

Endocrinopathy

Metabolic disorder

Glucose Metabolism Disorders

Insulin, Isophane

Insulin

Additional relevant MeSH terms:

Hypoglycemic Agents

Physiological Effects of Drugs

Pharmacologic Actions

ClinicalTrials.gov processed this record on September 19, 2008